These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37174593)

  • 41. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Reciprocal regulation between hypoxia-inducible factor-1alpha and its prolyl hydroxylases in hypoxic pulmonary hypertension rats].
    Chen YR; Dai AG; Hu RC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):668-73. PubMed ID: 17129494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silencing of HIF prolyl-hydroxylase 2 gene in the renal medulla attenuates salt-sensitive hypertension in Dahl S rats.
    Zhu Q; Hu J; Han WQ; Zhang F; Li PL; Wang Z; Li N
    Am J Hypertens; 2014 Jan; 27(1):107-13. PubMed ID: 24190904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of prolyl hydroxylase domain proteins in bone metabolism.
    Wolf D; Muralidharan A; Mohan S
    Osteoporos Sarcopenia; 2022 Mar; 8(1):1-10. PubMed ID: 35415275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
    An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
    J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
    Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
    Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.
    Takei A; Ekström M; Mammadzada P; Aronsson M; Yu M; Kvanta A; André H
    Sci Rep; 2017 Feb; 7():42546. PubMed ID: 28186209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3.
    Huang J; Zhao Q; Mooney SM; Lee FS
    J Biol Chem; 2002 Oct; 277(42):39792-800. PubMed ID: 12181324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.
    Li A; Zhang Y; Wang Z; Dong H; Fu N; Han X
    Chem Biol Interact; 2019 Apr; 303():40-49. PubMed ID: 30817904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of Hypoxia-Inducible Factor/Prolyl Hydroxylation Pathway in Deoxycorticosterone Acetate/Salt Hypertension in the Rat.
    Dallatu MK; Nwokocha E; Agu N; Myung C; Newaz MA; Garcia G; Truong LD; Oyekan AO
    J Hypertens (Los Angel); 2014 Dec; 3(6):. PubMed ID: 26185735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of Molecular Oxygen Diffusion in a Hypoxia-Sensing Prolyl Hydroxylase Using Multiscale Simulation.
    Domene C; Jorgensen C; Schofield CJ
    J Am Chem Soc; 2020 Feb; 142(5):2253-2263. PubMed ID: 31939292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E; Davies SL; Yeoh KK; Schofield CJ
    Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling.
    Wollenick K; Hu J; Kristiansen G; Schraml P; Rehrauer H; Berchner-Pfannschmidt U; Fandrey J; Wenger RH; Stiehl DP
    Nucleic Acids Res; 2012 Mar; 40(5):1928-43. PubMed ID: 22075993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of a novel prolyl hydroxylase 2 gene from mud crab Scylla paramamosain: Insights into its role in the regulation of hypoxia-inducible factor-1α.
    Jie YK; Jiang JJ; Ma HL; Cheng CH; Liu GX; Fan SG; Feng J; Guo ZX
    Comp Biochem Physiol C Toxicol Pharmacol; 2023 Jul; 269():109634. PubMed ID: 37086960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternative regulation of HIF-1α stability through Phosphorylation on Ser451.
    Han HJ; Saeidi S; Kim SJ; Piao JY; Lim S; Guillen-Quispe YN; Choi BY; Surh YJ
    Biochem Biophys Res Commun; 2021 Mar; 545():150-156. PubMed ID: 33550096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.
    Berra E; Benizri E; Ginouvès A; Volmat V; Roux D; Pouysségur J
    EMBO J; 2003 Aug; 22(16):4082-90. PubMed ID: 12912907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners.
    Deng H; Wang Z; Zhu C; Chen Z
    Front Oncol; 2024; 14():1370393. PubMed ID: 39007099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription.
    Mak P; Chang C; Pursell B; Mercurio AM
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4708-13. PubMed ID: 23487784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear-cytoplasmatic shuttling of proteins in control of cellular oxygen sensing.
    Depping R; Jelkmann W; Kosyna FK
    J Mol Med (Berl); 2015 Jun; 93(6):599-608. PubMed ID: 25809665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
    HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
    Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.